Revolutionary Zone IV Entry Control System Combines Advanced Ferromagnetic Detection with Intelligent Safety Analytics
NAPERVILLE, Ill., Nov. 30, 2025 /PRNewswire/ — Metrasens, the global leader in ferromagnetic detection technology, today announced the launch of Metrasens Vantage at the Radiological Society of North America (RSNA) annual conference. The innovative Zone IV entry control system represents a significant advancement in MRI safety, delivering the industry’s earliest threat detection combined with intelligent alert management and comprehensive AI-powered data and analytics.
Metrasens Vantage addresses one of MRI’s most critical safety challenges: preventing ferromagnetic objects from entering MRI environments where they can become dangerous projectiles. Unlike traditional systems that rely solely on magnetic detection, Vantage integrates multiple data streams—magnetic sensing, personnel movement tracking, and door status monitoring—to deliver context-aware alerts. By correlating these inputs, the system reduces false alarms and eliminates the alert fatigue that undermines staff vigilance and response effectiveness.
“MRI safety has always been about more than just detection—it’s about giving clinical care teams the clarity and confidence to act when it matters most,” said Dr. Simon Goodyear, CEO of Metrasens. “Metrasens Vantage transforms entry control from a reactive checkpoint into a proactive safety intelligence system. By understanding context and eliminating distractions, we’re empowering staff to focus on what truly matters: protecting patients and personnel.”
Intelligent Safety Through Advanced Technology
Metrasens Vantage integrates multiple sophisticated capabilities into a single, seamless system:
Early Detection Architecture – The system detects ferromagnetic threats before they reach the MRI door, providing the earliest possible warning and additional time for intervention when seconds are critical.
Customizable Detection Regions – Facilities can configure early and final detection zones to align with their specific Zone III layout and workflows, with tailored alert behaviors including permission-based alerts for authorized personnel.
Context-Aware Alerting – By processing inputs from people movements, magnetic signatures, and door status, Vantage interprets every signal in context to deliver only alerts that truly matter, significantly reducing nuisance alarms and alarm fatigue.
Smart Environmental Adaptation – Configurable blackout regions eliminate alerts from non-critical areas and nearby magnetic sources, keeping focus on genuine risks.
Comprehensive Event Intelligence – Seamless integration with Metrasens IQ transforms every detection event into actionable data, enabling managers to track key safety metrics, reconstruct incidents through event replay, generate compliance reports, and leverage AI-powered insights to identify trends and strengthen protocols.
Experience Vantage at RSNA
Conference attendees are invited to see Metrasens Vantage in action at North Hall — Booth 6750 throughout the conference:
About Metrasens
Metrasens is the global leader in ferromagnetic detection systems for MRI safety. The company’s advanced technologies protect patients, staff, and expensive MRI equipment in healthcare facilities worldwide. Metrasens combines decades of expertise in magnetic detection with innovative software and analytics to deliver comprehensive safety solutions that adapt to the evolving needs of modern medical imaging departments.
For more information about Metrasens Vantage, visit www.metrasens.com or stop by Booth 6750 at RSNA 2025.
SOURCE Metrasens
SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…
While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn…
DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and…
This Christmas season, President Trump's executive action to advance rescheduling and medical research has finally…
KANAZAWA, Japan, Dec. 26, 2025 /PRNewswire/ -- Scientists at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa…
LOS ANGELES, Dec. 25, 2025 /PRNewswire/ -- From January 6–9, 2026, visitors can experience Arspura's…